A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders
1 other identifier
observational
600
2 countries
3
Brief Summary
The current study is a prospective blinded study to collect data regarding the performance of the WP device in detecting sleep disorders. For that purpose, the WP with finger probe and chest sensor will be worn by the subject simultaneous to PSG in a sleep study at the clinical sleep lab. A PSG system will be recording the PSG data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2022
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 19, 2022
CompletedFirst Submitted
Initial submission to the registry
October 12, 2023
CompletedFirst Posted
Study publicly available on registry
October 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedAugust 22, 2025
August 1, 2025
3 years
October 12, 2023
August 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Apnea- Hypopnea Index (AHI)
Compares the results of the automatically scored AHI of the WP to the manually scored AHI of the PSG (Gold Standard). AHI is the average number of apnea and hypopnea events per hour of sleep
one night of sleep
Sleep Stages
Compares the results of the automatically scored sleep stages of the WP to the manually scored sleep stages of the PSG (Gold Standard). Stages are light sleep, deep sleep, REM or Wake.
one night of sleep
Secondary Outcomes (1)
Respiratory Disturbance Index (RDI)
one night of sleep
Eligibility Criteria
Subjects with suspected sleep disorders or patients with comorbidities that increase the likelihood of central sleep apnea who are referred for a sleep study.
You may qualify if:
- Age between 12-99
- Subjects that are able to read understand and sign the informed consent form of the study or by parents of subjects that are less than 18 years of age that are referred to undergo an overnight sleep study in the clinical sleep laboratory
- Subjects suspected of having sleep disorders or with comorbidities relevant to central sleep apnea.
You may not qualify if:
- Permanent pacemaker: atrial pacing or VVI without sinus rhythm.
- Finger deformity that precludes adequate sensor appliance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Johns Hopkins Bayview Asthma and Allergy Center
Baltimore, Maryland, 21224, United States
University of Maryland St. Joseph Medical Group, Pulmonary Care & Sleep Medicine
Towson, Maryland, 21286, United States
Tel-Aviv Medical Center
Tel Aviv, 6423906, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rivi Tauman, Prof,
Tel Aviv Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2023
First Posted
October 23, 2023
Study Start
September 19, 2022
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
August 22, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share